Chemical inhibitors of murine pregnancy-specific glycoprotein 16 (Psg16) can act upon various cellular mechanisms to impede the protein's normal function. Suramin, for instance, is known to inhibit cell adhesion molecules and growth factor signaling, which are crucial for the proper functioning of Psg16 in cell adhesion processes. Similarly, EDTA's role as a chelating agent allows it to sequester divalent cations like Ca2+ and Mg2+, which are essential for the activity of many cell adhesion molecules. Through this chelation, EDTA can disrupt the molecular interactions necessary for Psg16-mediated adhesion. The RGDS Peptide, with its ability to competitively inhibit integrin binding, can interfere with integrin-mediated cell adhesion, a pathway that may be closely associated with Psg16's role in cells.
In parallel, the broad-spectrum inhibitors TAPI-0 and Marimastat target protease families-ADAM and MMPs, respectively-that are implicated in the regulation of cell-matrix interactions and signaling. By inhibiting these proteases, TAPI-0 and Marimastat can indirectly affect the function of Psg16 related to these processes. GM6001, another MMP inhibitor, similarly can reduce extracellular matrix degradation, which is likely to influence Psg16's role in cell-matrix adhesion. The integrin antagonist Cilengitide can inhibit αvβ3 and αvβ5 integrins, directly affecting the cell adhesion mechanisms that Psg16 may utilize. Furthermore, Blebbistatin, as an inhibitor of myosin II ATPase activity, can alter the cytoskeletal dynamics that underlie cellular adhesion and migration, thereby influencing Psg16 function. LY294002, by inhibiting PI3K, can impede the signaling pathways that regulate cell proliferation and adhesion, potentially affecting the activity of Psg16. Additionally, the Src family kinase inhibitor PP2 can affect the signaling pathways that control cell adhesion, thus altering the function of Psg16. Lastly, PD98059 and SB203580, which inhibit the MAPK/ERK and p38 MAP kinase pathways, respectively, can modify the cell signaling environment and the expression of proteins involved in cell adhesion, which includes the activities of Psg16.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Suramin sodium | 129-46-4 | sc-507209 sc-507209F sc-507209A sc-507209B sc-507209C sc-507209D sc-507209E | 50 mg 100 mg 250 mg 1 g 10 g 25 g 50 g | $152.00 $214.00 $728.00 $2601.00 $10965.00 $21838.00 $41096.00 | 5 | |
Suramin is known to inhibit cell adhesion molecules and growth factor signaling. By disrupting cell adhesion molecule interactions, Suramin may inhibit Psg16-mediated cell adhesion processes. | ||||||
Marimastat | 154039-60-8 | sc-202223 sc-202223A sc-202223B sc-202223C sc-202223E | 5 mg 10 mg 25 mg 50 mg 400 mg | $168.00 $218.00 $404.00 $629.00 $4900.00 | 19 | |
Marimastat is a broad-spectrum matrix metalloproteinase (MMP) inhibitor. MMPs are involved in extracellular matrix remodeling and cell adhesion. Inhibition of MMPs could indirectly inhibit Psg16 function related to cell-matrix interactions. | ||||||
GM 6001 | 142880-36-2 | sc-203979 sc-203979A | 1 mg 5 mg | $77.00 $270.00 | 55 | |
GM6001, also known as Ilomastat, is another MMP inhibitor. By inhibiting MMP activity, GM6001 could reduce extracellular matrix degradation and potentially inhibit Psg16-related adhesion or signaling. | ||||||
Cilengitide | 188968-51-6 | sc-507335 | 5 mg | $215.00 | ||
Cilengitide is an integrin antagonist that inhibits the αvβ3 and αvβ5 integrins, which could be involved in Psg16-mediated cell adhesion. Inhibition of these integrins might inhibit the function of Psg16. | ||||||
(±)-Blebbistatin | 674289-55-5 | sc-203532B sc-203532 sc-203532A sc-203532C sc-203532D | 5 mg 10 mg 25 mg 50 mg 100 mg | $183.00 $313.00 $464.00 $942.00 $1723.00 | 7 | |
Blebbistatin is an inhibitor of myosin II ATPase activity. Since cellular adhesion and migration are dependent on cytoskeletal dynamics, blebbistatin could indirectly inhibit Psg16 by disrupting these processes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that could disrupt downstream signaling pathways involved in cell proliferation and adhesion. If Psg16 function depends on PI3K signaling, LY294002 could inhibit this function. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an Src family kinase inhibitor. Src kinases are involved in signaling pathways that regulate cell adhesion. Inhibition of Src kinases might reduce Psg16's role in these pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of the MAPK/ERK pathway, which is involved in cell growth and differentiation. Inhibition of this pathway could lead to the downregulation of proteins involved in cell adhesion, including Psg16. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a selective inhibitor of the p38 MAP kinase, which is involved in inflammatory responses and cell adhesion. By inhibiting p38 MAP kinase activity, SB203580 could impact Psg16-related signaling pathways. | ||||||